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INTRODUCTION
Influenza is a significant cause of morbidity 
and excess winter mortality in the UK.1,2 
Those at higher risk, including people with 
underlying health conditions such as cardiac 
or respiratory disease, and those aged 
≥65 years, are eligible for immunisation, 
the cost of which is met by the NHS.3 The 
World Health Organization recommends 
that at least 75% of people ≥65 years should 
be vaccinated,4 yet UK vaccination rates 
are lower than this.3 Strategies to increase 
vaccination have included encouraging 
general practices to increase access, and 
promoting early morning, evening, and 
weekend appointments.5 More recently, 
community pharmacists have been used 
as an alternative provider of influenza 
vaccination and this has been found to 
increase immunisation rates and meet 
service user needs.6–8
Community pharmacy-based vaccination 
is not a new phenomenon. In the US 
pharmacists have been giving influenza 
vaccinations since the mid-1990s.9,10 
In the UK a pilot was undertaken as 
early as 2002,11 and non-NHS influenza 
vaccination services are widely available 
from community pharmacies.12 There is 
evidence that vaccinations are given safely 
by pharmacists,13,14 and that access to 
pharmacies is greatest in areas of social 
deprivation,15 in which influenza vaccination 
rates are low.16
Influenza vaccination is an example of how 
pharmacies could contribute to improving 
public health and widening access. 
Pharmacy bodies in England have called for 
community pharmacies to take on aspects 
of GP workload as a potential solution to 
the workload pressures faced by GPs,17 and 
this view has been supported by the British 
Medical Association.18 The extent to which 
community pharmacies deliver influenza 
vaccination could be indicative of the sector’s 
capacity to make a significant contribution 
given previous concerns about their capacity 
to do so.12 However, other factors may 
influence the participation of individual 
pharmacists in extended roles; previous 
studies have shown that shortages of time, 
disruption to dispensing, vaccine availability, 
and lack of GP support are barriers to 
pharmacist involvement in vaccination 
programmes.12,19–27 The applicability of these 
studies is limited, however, as most were 
conducted outside the UK.
In July 2015, NHS England announced 
its intention to commission a national 
NHS influenza vaccination service from 
community pharmacies. The move has 
been controversial and, although it has been 
welcomed by pharmacy representatives,28 it 
has been met with resistance from those 
representing GPs. The latter have expressed 
concern about the adverse financial impact 
that pharmacy provision could have on GP 
practices.29,30 Before 2015, Wales was the 
only part of the UK to have a national 
pharmacy influenza service. This study 
provides an insight into the challenges that 
must be met for community pharmacies 
Research
Abstract
Background
Influenza is a significant cause of morbidity 
and excess mortality, yet vaccine coverage 
in the UK remains below target. Community 
pharmacies are increasingly being promoted as 
an alternative to vaccination by GPs.
Aim
To explore and verify the factors that influence 
the relative performance of pharmacies 
providing NHS influenza vaccinations.
Design and setting
A mixed methods study utilising qualitative, 
semi-structured interviews and quantitative 
analysis of predictors of vaccination numbers in 
community pharmacies in Wales.
Method
Interviews were conducted with 16 pharmacists 
who participated in the Welsh national 
pharmacy influenza service in 2013–2014. 
A purposive sampling strategy was used. 
Qualitative findings were analysed using 
framework analysis. Potential predictors of 
vaccination numbers were identified from 
interviews and a literature review, and included 
in a multivariable regression model.
Results
The contribution of community pharmacies 
towards vaccination in Wales is small. Findings 
suggest that community pharmacies reach 
younger at-risk individuals, in whom vaccine 
uptake is low, in greater proportion than 
influenza vaccination programmes as a whole. 
Extended opening hours and urban locations 
were positively associated with the number 
of vaccinations given, although pharmacists 
reported that workload, vaccine costs, 
unforeseen delays, lack of public awareness, 
and GPs’ views of the service limited their 
contribution. Pharmacists, aware of the potential 
for conflict with GPs, moderated their behaviour 
to mitigate such risk.
Conclusion
Before community pharmacies take greater 
responsibility for delivering healthcare services, 
obstacles including increasing pharmacist 
capacity, vaccine procurement, health service 
delays, managing GP–pharmacy relationships, 
and improving public awareness must be 
overcome.
Keywords
community pharmacy services; general 
practice; immunisation; pharmacy.
AM Evans, MPH, principal pharmacist in public 
health, Public Health Wales NHS Trust, Temple of 
Peace and Health, Cardiff. FC Wood, PhD, senior 
lecturer; B Carter, PhD, lecturer in medical statistics, 
Institute of Primary Care & Public Health, Cardiff 
University School of Medicine, Cardiff.
Address for correspondence
Andrew M Evans, Public Health Wales NHS Trust, 
Temple of Peace and Health, Cathays Park, Cardiff 
CF10 3AP, UK.
E-mail: andrew.evans7@wales.nhs.uk
Submitted: 23 September 2015; Editor’s response: 
30 November 2015; final acceptance: 17 
December 2015.
©British Journal of General Practice
This is the full-length article (published online 
11 Mar 2016) of an abridged version published in 
print. Cite this article as: Br J Gen Pract 2016;  
DOI: 10.3399/bjgp16X684349
Andrew M Evans, Fiona C Wood and Ben Carter
National community pharmacy NHS influenza 
vaccination service in Wales: 
a primary care mixed methods study
e248  British Journal of General Practice, April 2016 
to take an expanded role in influenza 
vaccination and other primary care services.
METHOD
A mixed methods study was conducted in 
Wales during 2014. The mixed methods 
approach was chosen to allow both the 
pattern of pharmacy vaccination and the 
reasons underlying that pattern to be 
explored. The qualitative phase explored 
pharmacists’ experiences of providing the 
service, including their views on facilitators 
and barriers, through telephone interviews. 
The findings of the qualitative phase 
informed the quantitative phase, which 
used data on NHS vaccinations obtained 
for all community pharmacies providing the 
pharmacy influenza vaccination service (‘the 
service’) in Wales between 1 October 2013 
and 31 March 2014. Data were provided by 
the NHS Wales Shared Services Partnership 
and included the number of vaccinations 
given, and age, sex, and self-reported 
eligibility of each person vaccinated. From 
pharmacist interviews and the literature, 
key factors that may explain the number 
of vaccinations given by pharmacies were 
explored. Potential predictors were found 
to be deprivation; workload; opening hours 
(that is, evening and weekend opening); 
ownership (that is, multiple or independent); 
and whether the pharmacy served a rural or 
urban area (Appendix 1).
The quantitative phase involved 
descriptive analysis of pharmacy activity 
data. The number of vaccinations given by 
pharmacies was transformed to the natural 
logarithmic scale and the relationship 
between the number of vaccinations and 
potential predictors was analysed by t-test 
for binary, and univariable linear regression 
for continuous variables. Explanatory 
variables and potential confounders found 
to explain vaccination numbers were 
subsequently included in a multivariable 
linear model. Analyses were carried out 
using Stata (version 13.1).
In the qualitative phase, the sampling 
frame included pharmacists if they practised 
at a pharmacy providing the service in the 
2013–2014 influenza season and provided 
at least one vaccination during that period. 
Pharmacists were identified by categorising 
pharmacies into performance quintiles on 
the basis of the number of vaccinations given. 
Pharmacies in the first (that is, providing 
the highest number of vaccines) and 
fourth quintiles were selected for detailed 
investigation, increasing the likelihood of 
identifying differing themes. Pharmacies in 
the fifth quintile were not selected because 
they gave too few vaccinations to have been 
able to form a sufficiently rounded view of 
all aspects of the service and its barriers 
and facilitators. From an initial list of 78, a 
purposive sample of 43 pharmacies was 
compiled with a balance of geographical 
distribution, ownership, dispensing volumes, 
and the proportion of vaccinations given to 
people not vaccinated in the previous influenza 
season. Pharmacists giving vaccinations 
at each of the pharmacies in the sample 
frame were identified by cross-referencing 
claims data with the online register of UK 
pharmacists maintained by the General 
Pharmaceutical Council (n = 44). A topic 
guide was devised from the literature review; 
interviews were audiotaped and transcribed. 
The resulting data were analysed using 
framework analysis.31 Transcripts were read, 
re-read, and annotated to identify the main 
themes and sub-themes. Annotations were 
coded with emerging codes continuously 
compared between transcripts. Data analysis 
was conducted by the principal investigator 
and overseen by the co-authors.
RESULTS
Number of vaccinations provided by 
pharmacies
A total of 7861 vaccinations were given from 
195 pharmacies (27.3% of the total number 
of pharmacies in Wales, n = 714) during 
the study period. The characteristics of 
pharmacies are shown in Table 1. The mean 
number of vaccinations per participating 
pharmacy was 40.31 (SD 46.95; n = 195). More 
than 100 vaccinations were given at 10.8% 
of pharmacies (21 out of 195); the highest 
number of vaccinations given at a single 
pharmacy was 282. Fifty-six pharmacies 
(28.7%) provided fewer than 10 vaccinations.
The total number of people receiving 
NHS influenza vaccination in Wales in 2013–
2014 was 668 780.32 The 7861 individuals 
How this fits in
The recent announcement from NHS 
England that all pharmacies could provide 
NHS influenza vaccinations from 2015 
has been met with resistance from GP 
representatives. Factors that influence the 
number of NHS influenza vaccinations 
given by pharmacies in the UK have not 
been evaluated. This study identified 
that extended opening hours and urban 
locations are positive predictors of 
vaccination numbers. Workload, vaccine 
costs, delays outside the pharmacists’ 
control, lack of public awareness, and 
GPs’ views of the service limited their 
contribution, however.
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vaccinated in pharmacies represent only 
1.18% of all those vaccinated. The mean 
age of individuals vaccinated in pharmacies 
(n = 7861) was 60.3 years (95% CI = 59.9 to 
60.6 years, range 18–100 years). Data on sex 
were available for 7854 claims (99.9%). Most 
vaccines were given to females (4533, 57.7% 
versus 3321, 42.3%).
The most common eligibility criterion was 
being aged ≥65 years (4081, 51.9%, Table 2).
The proportion of people aged <65 years 
and in a clinical risk group vaccinated was 
higher in pharmacies than the proportion 
across the vaccination programme as a 
whole (pharmacies 2812, 35.8%; programme 
163 377, 24.4%, mean difference 11.3%, 
95% CI = 10.3% to 12.4%, P<0.001).33
Reported vaccination histories were 
available for all 7861 individuals vaccinated: 
1960 individuals (24.9%) reported having 
not been vaccinated in 2012–2013, a 
further 5035 (64.1%) were vaccinated by 
their GP, and 485 (6.2%) received an NHS 
pharmacy vaccination, with the remaining 
381 individuals (4.8%) vaccinated at a range 
of locations including vaccination provided 
by their employer and paid for vaccination 
at a community pharmacy.
Predictors of vaccination numbers
The results of the univariable analyses are 
shown in Tables 3 and 4. After including 
statistically significant predictors in a 
multivariable model there was some 
evidence of a difference in the mean number 
of vaccinations, although neither having 
an urban location (regression coefficient 
0.37, 95% CI = –0.05 to 0.78, P = 0.08) nor 
having extended opening hours (regression 
coefficient 0.55, 95% CI = –0.03 to 1.12, 
P = 0.06) reached statistical significance at 
the 95% confidence level.
Pharmacist interviews
In total 44 pharmacists were invited to 
participate in the study. Sixteen responded, 
giving a response rate of 36.4%. The 
characteristics of participants are shown 
in Table 5. Data saturation was assessed 
after 15 interviews, and recruitment was 
continued to 16 interviews to ensure the 
number of interviews with pharmacists 
from the high- and low-giving quintiles was 
equal.
Interviews identified three main themes: 
pharmacy factors; public awareness; 
and external factors. These with the sub-
Table 1. Characteristics of pharmacies participating in NHS seasonal 
influenza vaccination service 2013–2014
  Participating Non-participating 
 All pharmacies, n (%) pharmacies, n (%) pharmacies, n (%)
Pharmacy type
 Independent 240 (33.61) 47 (24.10) 193 (37.19)
 Multiple 474 (66.39) 148 (75.90) 326 (62.81)
Rural Urban Classification     
 Urban 507 (71.01) 136 (69.74) 371 (70.13)
 Rural 199 (27.87) 56 (28.71) 153 (28.92)
 Not available  8 (1.12) 3 (1.54) 5 (0.95)
Deprivation quintile     
 1 (lowest) 94 (13.17) 22 (11.28) 72 (13.87)
 2 96 (13.45) 28 (14.36) 68 (13.10)
 3 174 (24.37) 52 (26.67) 122 (23.51)
 4 180 (25.21) 54 (27.69) 126 (24.28)
 5 (highest) 170 (23.81) 39 (20.00) 131 (25.24)
Extended-hours pharmacy     
 Yes 37 (5.18) 24 (12.31) 13 (2.50)
 No 677 (94.82) 171 (87.69) 506 (97.50)
Average monthly prescription volume quintile     
 1 (lowest) 143 (20.03) 37 (18.97) 106 (20.42)
 2 143 (20.03) 39 (20.00) 104 (20.04)
 3 143 (20.03) 36 (18.46) 107 (20.62)
 4 143 (20.03) 46 (23.59) 97 (18.69)
 5 (highest) 142 (19.89) 37 (18.97) 105 (20.23)
Total 714 195 519 
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themes and codes emerging under each are 
detailed in Table 6. The main themes, and 
most significant sub-themes, are discussed 
in a linear fashion; however, many are 
intrinsically linked. The perceptions of 
pharmacists giving comparatively high and 
low numbers of vaccinations are discussed 
together using illustrative quotes with 
participants identified by the codes H and 
L, respectively.
Pharmacy factors. How does pharmacy 
workload affect participation? Half of the 
pharmacists (n = 8) reported that workload 
was an important determinant of the 
number of vaccinations. In particular, 
having more than one pharmacist present 
helped by preventing disruption to the other 
activities:
‘... we’ve got two pharmacists here so it 
means that dispensing continues without 
disrupting the normal day-to-day activities.’ 
(H5)
Some (n = 8) reported prioritising 
vaccination over other services:
‘I did do less MURs [Medicine Use Reviews], 
part of that because I was doing vaccinations 
and had the other services to deal with.’ (L5)
One pharmacist gave an insight into 
pharmacies’ capacity to provide the service:
‘... there’s just not enough pharmacist hours 
in branch to do everything that pharmacists 
need to do … because we are busy you kind 
of don’t drive it as much as you could.’ (L5)
How do a pharmacy’s opening hours 
affect provision? A few pharmacists who 
provided a comparatively high number of 
vaccinations considered the availability of 
vaccination at weekends, at lunchtime, and 
in the evening specifically to be important 
determinants of vaccination numbers:
‘They also liked our opening times as well. 
They liked that you could come in in the 
evening and have it done.’ (H6)
‘I’ve got a friend who’s an electrician he’s 
working till half five at night goes out to 
work at half eight in the morning. He came 
to see me on a Saturday afternoon and had 
his flu vaccination.’ (H1)
This was corroborated by comments 
from pharmacists who gave low numbers 
of vaccines:
‘We don’t open on a Sunday … we close at 
lunchtime.’ (L6)
Pharmacists reported taking different 
approaches to delivery of the service and 
their role to support increasing vaccine 
uptake. These approaches can be split into 
two broad categories. The first, predominant 
among pharmacists giving comparatively 
high numbers of vaccinations, was 
to adopt a structured approach. This 
included ensuring that the pharmacy had 
facilities and processes that supported 
service delivery, improving efficiency, and 
maximising capacity to offer the service:
‘I think it was because I had everything 
to hand, everything laid out, I had all the 
paperwork. I planned the paperwork so I 
got each person that’s going to present I’ve 
already prepped 10 or 20 forms ready for 
them to turn up on a rolling basis.’ (H5)
‘We booked appointments to make sure 
we did have staff in that could deliver the 
vaccinations.’ (H8)
There are potentially many reasons why a 
pharmacy would adopt this approach. One 
pharmacist explained:
‘Every service we do we are quite keen that 
it’s gotta be profitable, there’s no point, we 
don’t see the point of doing something that 
doesn’t benefit profitability in any way.’ (H2)
Table 2. Number of NHS 
seasonal influenza vaccinations 
provided by community 
pharmacies in Wales by NHS 
eligibility criteria 2013–2014 
(n = 7861)
Eligibility criteria n (%)
Aged ≥65 years 4081 (51.9)
Chronic respiratory diseasea 1564 (19.9)
Diabetesa 639 (8.1)
Carer 571 (7.3)
Chronic heart diseasea 280 (3.6)
Pregnancy 233 (3.0)
Immunosuppresseda 174 (2.2)
Chronic neurological diseasea 95 (1.2)
Other (as specified in PGD) 76 (1.0)
Household contact of  40 (0.5) 
immunocompromised individuals 
Chronic kidney diseasea 38 (0.5)
Designated first aider 34 (0.4)
Chronic liver diseasea 20 (0.3)
People living in long-stay  10 (0.1) 
residential care homes or other  
long-stay care facilities 
Community first responder 6 (0.1)
Total 7861
aClinical risk groups in those aged <65 years. PGD 
= Patient Group Direction.
Table 3. Association between (continuous variable) predictors and the 
number of NHS influenza vaccinations
Predictor β coefficient P-value 95% CI
Deprivation score 0.010 0.893 –0.131 to 0.015
Average monthly prescription volume 0.020 0.351 –0.022 to 0.062
Table 4. Association between (binary variable) predictors and the 
number of NHS influenza vaccinations
  Mean difference in 
Predictor n number of vaccinations 95% CI P-value
Rural Urban Classification     
 Rural location 56 – – –
 Urban location 136 8.385 –1.712 to 18.260 0.032
Trading hours     
 Normal 171 – – –
 Extended 24 15.796 –2.343 to 42.964 0.031
Pharmacy ownership     
 Multiple  148 – – –
 Independent  47 6.506 –5.750 to 21.420 0.175
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Most pharmacists (n = 5) adopting a 
structured approach also implied that they 
were more responsive to people’s demands 
than were GP surgeries:
‘... you have to book an appointment at 
the surgery, there are only certain surgery 
times … so the patients liked it in terms of 
they could just walk in and have it straight 
away.’ (H6)
The second approach could be described 
as altruistic and was prevalent among 
pharmacists providing comparatively low 
numbers of vaccinations, who emphasised 
that providing vaccinations was, for the 
pharmacy profession in the UK, a recent 
development. These pharmacists took what 
they saw as a more public service (and 
ultimately conservative) approach.
Some of these pharmacists (n = 3) 
described offering a ‘mop up’ service, 
referring to only vaccinating people who 
had difficulty getting to their GP. These 
pharmacists deferred to GPs as the 
predominant provider:
‘We were always going to be a support service 
to them [GPs], for those people that couldn’t 
get to them for whatever reason.’ (L4)
They also avoided criticising practices’ 
vaccination arrangements and reported 
taking steps to minimise and avoid conflict 
with local GPs:
‘We could have more proactively promoted 
it but didn’t particularly want to step on the 
GPs’ toes.’ (L3)
Taking a more assertive approach was 
considered a risky strategy that would 
damage relationships with GPs, with a more 
substantial adverse impact on business in 
the longer term:
‘If you try and push too much it does get 
their back up a bit and when you’ve got 
good relationships, I know some of the big 
companies are really hammering it and 
what you gain there you lose in a lot of other 
things.’ (L8)
Only two pharmacists, however, reported 
that providing the service had had a 
detrimental impact on relationships with GPs: 
‘... [the practice manager] was very much 
concerned with the fact that we were solely 
there to try and mop up.’ (L1)
‘Once they saw a lot of patients choosing to 
come here [to the pharmacy] straight away 
they got really, really defensive and made all 
Table 5. Characteristics of interview participants
  Years     Full-/ 
Participant  in pharmacy  Postgraduate Position in Pharmacy part-time 
number Sex practice qualifications pharmacy type working
H1 M 16–20 None Owner Ind Full
H2 M 6–10 Certificate Employee Ind Full
H3 F 16–20 PhD Manager Mt Part
H4 M 1–5 None Manager Mt Full
H5 F 11–15 Masters Manager Ind Part
H6 F 11–15 Diploma Employee Mt Full
H7 F ≥31 None Manager Mt Full
H8 M 6–10 Diploma Employee Mt Full
L1 M 11–15 Diploma Owner Ind Full
L2 M 26–30 Certificate Owner Ind Full
L3 F 26–30 None Employee Mt Part
L4 M 21–25 Masters Owner Ind Full
L5 F 6–10 Diploma Manager Mt Full
L6 F ≥31 None Manager Mt Full
L7 M 26–30 None Owner Ind Full
L8 F 6–10 None Manager Mt Part
F = female. H = provided high number of vaccinations. Ind = independent. L = provided low number of vaccinations. M 
= male. Mt = multiple.
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kinds of sort of threats to try and stop me 
from doing it.’ (H4)
Positively, the second of these 
pharmacists reported that the local health 
board (LHB) provided mediation and that 
he had been able to work more closely with 
GPs afterwards:
‘The LHB sort of intervened and told the 
GP you can’t do that and suggested maybe 
they would provide us with a list of eligible 
patients that didn’t get it last year, which 
they did and that worked quite well. We 
were able to target those patients.’ (H4)
Some pharmacists (n = 4) reported 
that GPs had responded positively to the 
pharmacy providing the service, even 
encouraging people to use it:
‘The biggest surgery locally were directing 
people if they missed the GPs’ appointment, 
GPs’ days for doing vaccinations, were 
saying oh [pharmacist’s name] is doing it 
over in the chemist. If you go over there she 
might be able to do them for you.’ (H5)
A high number of pharmacists (n = 7) 
reported being unaware of strong views, 
either positive or negative, from GPs.
Over half of pharmacists (n = 9) thought 
that public awareness of pharmacy 
influenza vaccination was poor:
‘People didn’t know about the service.’ (L5)
‘… not terrific awareness for the NHS jabs, 
I think that missed out almost entirely. I’m 
struggling to think of people who came in 
and said I’ve heard you do NHS flu jabs, can 
I have one?’ (H7)
‘When we talk to people about it they 
are not always aware that we can do it. 
Stemming from that maybe an increased 
awareness would mean more people 
getting vaccinated.’ (H8)
External factors. Most pharmacists (n = 10) 
commented on the impact of various 
procedural delays. In particular, they 
reported that there had been a delay in 
receiving the Patient Group Direction (PGD), 
which provided the necessary authority to 
give vaccinations:
‘... we didn’t actually get the PGD until the 
week the service started.’ (L6)
‘... it was a very slow burner to start off but 
it was because the paperwork and all the 
Table 6. Themes, sub-themes, and codes describing pharmacists’ 
views of the determinants of the number of NHS influenza vaccinations 
provided at pharmacies
Main theme Sub-themes Codes 
Pharmacy factors Pharmacist numbers Other pharmacist(s) available to maintain day-to-day 
  functions of the pharmacy
  Maximising the number of pharmacists able to immunise 
  Reliance on pharmacist to provide the (flu) service
 Extended trading Evening opening hours
  Weekend opening hours
 Pharmacy location Proximity/co-location with GP practice
  Footfall
  Pharmacy as part of defined community
  Rurality
  Town centre
  Population served by pharmacy
 Staff support Delegation of roles to staff
  Training
  Recruiting patients
 Flexibility to offer  Drop in/no appointments needed 
 vaccinations 
 Identifying patients Checking against prescriptions 
  Promoting vaccination to people accessing other 
  pharmacy services
  Targeting specific at-risk groups
 Planning approach Business focus — profitability
  Providing a high-quality professional service (altruism)
  Capacity or absence of planning
  Planning to supplement (mop up) GPs
 Impact on other Reducing level of other services to accommodate 
 services vaccination
 Premises/facilities Number of consultation rooms
Public awareness Word of mouth Snowballing
  Staff raising awareness
 Promotional material Corporate display materials
  Insufficient/inadequate/delayed promotional materials
  Promotional displays
  Restrictions on advertising
  No awareness of NHS service
  Decision not to promote by pharmacy
  Importance of flu vaccination/eligibility
External factors Finance Profit motive
  Incentives
  Unimportance of profit
 GP relationships Reciprocity
  Conflict avoidance
  Views of GPs and practice staff
 Vaccine availability Supply chain shortages
  Purchasing restrictions
  Uncertain demand
 Administrative burden Paperwork
 Commissioning processes Accreditation processes
  Patient Group Direction 
  Approval by health board
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sign-off for the PGD didn’t come through 
until after all of our local surgeries had 
already run their flu clinics.’ (L5)
Some pharmacists (n = 4), particularly 
those providing comparatively low numbers, 
thought preparation for the service had 
been poor, specifically identifying LHB 
disorganisation as a problem:
‘They [the LHB] don’t strike me as 
particularly organised. Stuff needs to get to 
us on time, well in advance really not just 
scraping through.’ (L7)
‘Everything came through from the Health 
Board fairly late on to be honest.’ (H7)
Of the pharmacists interviewed who had 
given a comparatively low number, half 
(n = 4) reported difficulties with securing 
adequate supplies of vaccine:
‘I kept on reordering and reordering. 
Eventually they just stopped coming in and 
then there was a shortage.’ (L5)
‘I’d say oh I’ve run out but I should have 
some in tomorrow you can try ringing 
about, and they never used to come back 
then … we’d have done more if we’d had the 
reliability of the supply chain.’ (L5)
Others (n = 2) reported that, although 
they were able to obtain vaccines, the costs 
of doing so resulted in a financial loss 
for the pharmacy. The result of this was 
that they faced a choice between meeting 
either their professional or commercial 
obligations. This was a scenario in which 
there was no satisfactory resolution:
‘I had to buy them [vaccines] in tens which 
meant that three of them were wasted. So 
I don’t know that I made any money at all 
last year but I’m not completely interested 
in that I’m also happy to provide a service 
… what do they [the LHB] want me to think 
when I open the new box, think I’m never 
gonna get rid of these 10 [vaccines], turn 
them [members of the public] all away … 
They’re risking us, risking us turning three 
or four people away.’ (L2)
DISCUSSION
Summary
This study highlights the complexity of 
delivering extended primary care services 
consistently through community pharmacies. 
The contribution of community pharmacies 
towards vaccination in Wales is small. 
Although some pharmacies demonstrated 
that they could provide a comparatively 
high number of vaccinations, most provide 
comparatively few. Positive findings suggest 
that community pharmacies reach younger 
at-risk individuals, in whom vaccine uptake 
is low, in greater proportion than influenza 
vaccination programmes as a whole. 
Extended opening hours and urban locations 
were positively associated with the number 
of vaccinations given.
Strengths and limitations
This is the first study that has examined 
both quantitatively and qualitatively the 
association between predictors and the 
number of pharmacy vaccinations, taking 
into account all pharmacy types, locations, 
opening hours, and workload. It is also the 
first study designed specifically to assess 
determinants of influenza vaccine provision 
by pharmacists in the UK.
A limitation is perhaps the measurement 
of the performance of pharmacies in 
numbers of vaccines given, which assumes 
that all pharmacies serve a broadly similar 
at-risk population. Participants were 
volunteers who may have overstated their 
enthusiasm or how well the service was 
received by patients, or understated GP 
resistance, particularly if they believed this 
was critical to ensuring that they were 
commissioned in the future. All participants 
were providing NHS influenza vaccinations 
and findings cannot necessarily be applied 
to all pharmacies.
Comparison with existing literature
Extended opening hours and an urban 
location were positively associated with the 
number of vaccinations given, supporting 
previous qualitative studies;6,11,34 however, 
the effect size was small and, after 
adjusting for confounding, neither predictor 
reached statistical significance. Contrary 
to previous studies, no associations were 
observed between deprivation, pharmacy 
workload, and pharmacy ownership20,22–26 
and vaccination numbers.
Pharmacist interviews generally reflected 
the findings of previous research,12 and 
suggested that the relative performance 
of a pharmacy may be explained more 
adequately by the complex interplay between 
that pharmacy and external factors, specific 
to that pharmacy, than by population-level 
measures. The potential for the service to 
bring pharmacists and GPs into conflict is 
a key determinant of the approach taken 
by pharmacists. This is consistent with 
the findings of previous research,23,25,35 as 
are the findings suggesting that having 
a robust supply chain,36 and more than 
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one pharmacist being available, facilitate 
service provision.8,20,22
Implications for research and practice
These findings raise questions about how 
prepared community pharmacies are to 
take on services currently provided by GPs. 
The pharmacy profession has welcomed 
the availability of NHS vaccination 
from community pharmacies but the 
performance of individual pharmacies is 
variable and the overall contribution to 
vaccine uptake is low. Workload, lack of 
public awareness, vaccine procurement, 
health service disorganisation, and conflict 
with GPs were obstacles that prevented 
pharmacies making a greater contribution. 
Pharmacists, aware of the potential for 
conflict between themselves and GPs, 
moderated their behaviour to mitigate 
such risk. This has implications for both 
influenza vaccination and other services in 
which GPs and pharmacists may be seen 
to be competing for the same patients. 
The challenge for policymakers is to find a 
way of fostering collaboration between the 
professions for population benefit.
Interview findings suggest that, where 
there is insufficient capacity within 
community pharmacies to increase their 
range of services, they will prioritise 
service provision. In doing so the benefits 
of increased activity in one service will be 
offset by reductions in another. Prioritisation 
decisions will be made based on each 
pharmacist’s values, which may or may not 
be aligned with those of policymakers. It is 
conceivable that, in some cases, increasing 
the number of community pharmacy 
services could be counterproductive. 
Policymakers and community pharmacists 
must ensure that, in making them available, 
pharmacies have capacity to deliver existing 
as well as new services effectively.
Future research should explore the 
finding that pharmacies may be suited 
to vaccinating individuals who are aged 
<65 years and at risk (Table 2). Vaccination 
rates in this group remain persistently 
low. Promoting community pharmacies to 
this group may support efforts to increase 
uptake. Research is also warranted to 
quantify what effect having more than one 
pharmacist present at a pharmacy has 
on service delivery, and to verify whether 
pharmacists opting out of providing 
influenza services report similar barriers to 
service provision.
In the UK, increasing the range of 
services, including influenza vaccination, 
provided by community pharmacies is 
promoted as a means to reducing GP 
workload. For this to happen, obstacles 
including health service disorganisation, 
increasing pharmacist capacity, managing 
GP–pharmacy relationships, improving 
vaccine procurement arrangements both to 
mitigate the risk to GP practices of reduced 
service income and to remove disincentives 
for pharmacies, and  finally, improving 
public awareness must be overcome. This 
requires action from pharmacists, GPs, and 
policymakers.
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Appendix 1. List of explanatory variables (predictors) used in analysis 
Predictor Source
Pharmacy ownership type NHS Wales Shared Services Partnership
Rural Urban Classification Office for National Statistics
WIMD Public Health Wales Observatory
Pharmacy opening hours NHS Wales Shared Services Partnership
Average monthly prescription volume (‘000s) NHS Wales Shared Services Partnership
WIMD = Welsh Index of Multiple Depression.
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